Rosenblatt Maintains Buy on Calix, Lowers Price Target to $55

Benzinga Newsdesk www.benzinga.com Negative 53.2%

Neg 53.2% Neu 0% Pos 0%

Rosenblatt analyst Mike Genovese maintains Calix (NYSE:CALX) with a Buy and lowers the price target from $70 to $55.

Comments

No comments yet. Be the first!